Principal involvement of cyclooxygenase-1-derived prostaglandins in the c-fos expression of the rat hind brain following visceral stimulation with acetic acid

Molecular Brain Research

Volumn 52, Issue 1, 1997, Pages 151-156

  Kusuhara, Hidenobu ^a   Fukunari, Atsushi ^a   Matsuyuki, Hirofumi ^a   Okumoto, Takeki ^a  

^a Research Laboratories   (Japan)

Author keywords

c fos; Cyclooxygenase; Mofezolac; mRNA expression; Nociception; Non steroidal anti inflammatory drug; NS 398; Prostaglandin

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETIC ACID; CYCLOOXYGENASE 1; MESSENGER RNA; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; NONHUMAN; ONCOGENE C FOS; PERITONEUM; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; RHOMBENCEPHALON;

ACETIC ACID; ANIMALS; CYCLOOXYGENASE 1; FEMALE; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RHOMBENCEPHALON; STIMULATION, CHEMICAL; VISCERA;

EID: 0030731220     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00263-5     Document Type: Article

References (23)

1. Beiche F., Scheuerer S., Brune K., Geisslinger G., Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 390:1996;165-169.
2. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
3. Cutrer F.M., Moussaoui S., Garret C., Moskowitz M.A. The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation. Neuroscience. 64:1995;741-750.
4. Davies P., Bailey P.J., Goldenberg M.M., Ford-Hutchinson A.W. The role of arachidonic acid oxygenation products in pain and inflammation. Annu. Rev. Immunol. 2:1984;335-357.
5. Day H.E.W., Akil H. Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1-beta: implications for mechanism of action. Neuroendocrinology. 63:1996;207-218.
6. Doherty N.S., Beaver T.H., Chan K.Y., Dinerstein R.J., Diekema K.A. The antinociceptive activity of paracetamol in zymosan-induced peritonitis in mice: the role of prostaglandin and oxygen species. Br. J. Pharmacol. 101:1990;869-874.
7. Draisci G., Iadarola M.J. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol. Brain Res. 6:1989;31-37.
8. Elliott K.J., Brodsky M., Hynansky A.D., Foley K.M., Inturrisi C.E. Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA. Pain. 61:1995;401-409.
9. Ferreira S.H. Inflammatory pain, prostaglandin hyperalgesia and the development of peripheral analgesics. Trends Pharmacol. Sci. 2:1981;183-186.
10. Fukunari A., Kato A., Sakai Y., Yoshimoto T., Ishiura S., Suzuki K., Nakajima T. Colocalization of prolyl endopeptidase and amyloid β-peptide in brains of senescence-accelerated mouse. Neurosci. Lett. 176:1994;201-204.
11. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 47:1994;55-59.
12. Gans K.R., Galbraith W., Roman R.J., Haber S.B., Kerr J.S., Schmidt W.K., Smith C., Hewes W.E., Ackerman N.R. Anti-inflammatory and safety profile of Dup 697, a novel orally effective prostaglandin synthesis inhibitor. J. Pharmacol. Exp. Ther. 254:1990;180-187.
13. Gogas K.R., Levine J.D., Basbaum I. Differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids: an analysis of formalin-evoked c-Fos expression. J. Pharmacol. Exp. Ther. 276:1996;801-809.
14. Halzonetis T.D., Georgeopoulos K., Greenberg M.E., Leder P. c-jun dimerizes with itself and with c-fos forming complexes of different DNA binding abilities. Cell. 55:1988;917-924.
15. Hamba M., Muro M., Hiraide T., Ozawa H. Expression of c-fos like protein in the rat brain after injection of interleulin-1-beta into the gingiva. Brain Res. Bull. 34:1994;61-68.
16. Hunt S.P., Pini A., Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature. 328:1987;632-634.
17. Kusuhara H., Komatsu H., Hisadome M., Ikeda Y. (±)-3-[4-(2-Dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4-b] pyridine-1-acetic acid (Y-25510) stimulates production of IL-1β and IL-6 at the level of mRNA expression in cultured human monocytes. Int. J. Immunopharmacol. 18:1996;719-728.
18. Lantéri-Minet M., Isnardon P., de Pommery J., Menetrey D. Spinal and hindbrain structures involved in visceroception and visceronociception as revealed by the expression of Fos, Jun and Krox-24 proteins. Neuroscience. 55:1993;737-753.
19. S. Moncada, S.H. Ferreira, J.R. Vane, Pain and inflammatory mediators. in: J.R. Vane, S.H. Ferreira (Eds.), Handbook of experimental pharmacology, Springer, Berlin, 1978, pp. 558-616.
20. Ono N., Yamamoto N., Sunami A., Yamasaki Y., Miyake H. Pharmacological profile of mofezolac, a new non-steroidal analgesic anti-inflammatory drug. Folia Pharmacol. Jpn (Tokyo). 95:1990;63-81.
21. A. Paxinos, A. Watson, The rat brain in stereotaxic coordinates, Acadmic press, New York, 1997.
22. Sassone-Corsi P., Ransone L.J., Lamph W.W., Verma I.M. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain. Nature. 336:1988;692-695.
23. Shankland S.J., Scholey J.W. Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int. 46:1994;430-442.